Ei S, Mihaljevic AL, Kulu Y, et al. - Since the feasibility and safety of minimally invasive enucleation (ME) for benign or borderline pancreatic tumors is still uncertain, researchers sought to compare outcomes between ME and open enucleation (OE). Between October 2001 and January 2020, all patients undergoing pancreatic enucleation were analyzed from a prospective database. There were 358 patients undergoing enucleation, 120 matched patients (ME n = 40, OE n = 80) involved. ME lowered the amount of bleeding compared with conventional OE and facilitates earlier postoperative discharge with no raising the occurrence of major complications. Where technically and oncologically feasible, minimally invasive enucleation of benign pancreatic tumors should be considered.